Who is the invited lecturer for the JPI seminar on building a drug discovery ecosystem?

The invited lecturer is Mr. Yasuhiro Araki, the Director of the Clinical Trial Promotion Office at the Ministry of Health, Labour and Welfare.

What is the specific date and time scheduled for the JPI seminar?

The seminar is scheduled to take place on Thursday, April 09, 2026, from 09:30 to 11:30.

What is the definition of the drug loss problem described in the text?

The drug loss problem refers to the situation where medicines approved in Europe and the United States are not developed in Japan.

What are the three goals of the discussions between Japan's public and private sectors?

The goals are to strengthen Japan's drug discovery capabilities, rapidly deliver the latest medicines to the public, and build a sustainable cycle of investment and innovation.

Can people register or apply for the seminar after the live event has ended?

Yes, applications for archive streaming of the seminar will be accepted even after the seminar has concluded.

AI News NQ Analysis

[JPI Seminar] Ministry of Health, Labour and Welfare "Building a Drug Discovery Ecosystem and Measures to Promote Clinical Trials" to be held on Thursday, April 9th

NQ Score 50/100

AI analysis data is not yet available.

Frequently Asked Questions

Q: Who is the invited lecturer for the JPI seminar on building a drug discovery ecosystem?: A: The invited lecturer is Mr. Yasuhiro Araki, the Director of the Clinical Trial Promotion Office at the Ministry of Health, Labour and Welfare.
Q: What is the specific date and time scheduled for the JPI seminar?: A: The seminar is scheduled to take place on Thursday, April 09, 2026, from 09:30 to 11:30.
Q: What is the definition of the drug loss problem described in the text?: A: The drug loss problem refers to the situation where medicines approved in Europe and the United States are not developed in Japan.
Q: What are the three goals of the discussions between Japan's public and private sectors?: A: The goals are to strengthen Japan's drug discovery capabilities, rapidly deliver the latest medicines to the public, and build a sustainable cycle of investment and innovation.
Q: Can people register or apply for the seminar after the live event has ended?: A: Yes, applications for archive streaming of the seminar will be accepted even after the seminar has concluded.